Skip to main content

Regulatory Guidance on Bioanalytical Method Validation

 The Food and Drug Administration (FDA), European Medicinal Agency (EMA), and International Consortium for Harmonization (ICH)  have issued guidances that are intended to provide recommendations for the validation of bioanalytical assays for chemical and biological drug quantification and their application in the analysis of study samples. 


Type of Bioanalytical Method Validation
Full Validation 
Bioanalytical method validation is essential to ensure the acceptability of assay performance and the reliability of analytical results. A bioanalytical method is defined as a set of procedures used for measuring analyte concentrations in biological samples. 

Full Validation

Full validation of a bioanalytical method should be performed when establishing a bioanalytical method for the quantification of an analyte in clinical and in pivotal nonclinical studies. Full validation should also be performed when implementing an analytical method that is reported in the literature and when a commercial kit is repurposed for bioanalytical use in drug development.
A specific, detailed, written description of the bioanalytical method should be established a priori. This description may be in the form of a protocol, study plan, report, or Standard Operating Procedure (SOP).

Partial Validation
Modifications to a fully validated analytical method may be evaluated by partial validation. Partial validation can range from as little as one accuracy and precision determination to nearly full validation. The items in a partial validation are determined according to the extent and nature of the changes made to the method. 

Cross-Validation
Where data are obtained from different methods within or across studies, or when data are obtained within a study from different laboratories applying the same method, comparison of those data is needed and cross-validation of the applied analytical methods should be carried out.

Method Validations Parameter Include: 
Reference standards
Critical reagents
Calibration curve
Quality control samples (QCs) 
Selectivity and specificity 
Sensitivity
Accuracy
Precision
Recovery
Stability of the analyte in the matrix
Minimum Required Dilution (MRD)

For Details Visit


Comments

Popular posts from this blog

Carbohydrate Metabolism: MCQs and answers on Glycolysis & Gluconeogenesis

                                      MCQ on Glycolysis & Gluconeogenesis 1) Which of the following enzyme is not involved in galactose metabolism? a) Glucokinase b) Galactokinase c) Galactose-1-Phosphate Uridyl transferase d) UDP-Galactose 4- epimerase 2) Which of the following enzyme is defective in galactosemia (type I) - a fatal genetic disorder in infants? a) Glucokinase b) Galactokinase c) Galactose-1-Phosphate Uridyl transferase d) UDP-Galactose 4- epimerase 3) In the liver, the accumulation of which of the following metabolite attenuates the inhibitory of ATP on phosphofructokinase? a) Glucose-6-Phosphate b) Citrate c) Fructose-1,6-Bisphosphate d) Fructose-2,6-Bisphosphate 4) Mutation in which of the following enzymes leads to a glycogen storage disease known as "Tarui’s disease"? a) Glucokinase b) Phosphofructokinase c) Phosphoglucomutase d) Pyruvate Kinase 5) E...

Multiple Choice Questions (MCQs) on Diabetes Mellitus: Pathogenesis, Diagnosis and Treatment

                                        MCQs on Diabetes mellitus 1) Diabetes mellitus is a disorder characterized by hyperglycemia.  Which of the following is not the common characteristic features of type 2 diabetes mellitus ? a) Impaired insulin secretion b) Increased Insulin resistance  c) Diabetic ketoacidosis d) Excessive hepatic glucose production 2) Which of the following are the characteristic features of type 1 diabetes mellitus? a) Type 1 diabetes is caused by an absolute deficiency of insulin. b) Type 1 diabetes is associated with the autoimmune destruction of beta cells.  c) Patients with  uncontrolled type 1 diabetes present with diabetic ketoacidosis d) All of the above   3) Which of the following serum measurements are not used for the diagnosis of diabetes mellitus? a) Fasting blood glucose d) Postprandial blood glucose  c) Insulin ...

MCQs on Superficial and Cutaneous Mycoses-Dermatophytes: Medical Mycology

  Multiple Choice Questions on Superficial and Cutaneous Fungal Infections 1. All of the following are examples of common superficial mycoses, EXCEPT ? a) Aspergillosis b) Candidiasis c) Tinea versicolor d) Tinea nigra 2. Which of the following statement regarding Tinea nigra infection is NOT correct? a) Most prevalent in the tropical and subtropical region b) Symptoms include pigmented macules on palm and soles c) Trycophyton spp is the causative fungi d) Common specimen is skin scrapings 3. The fungi Trichosporon commonly causes superficial infection of hair also called white piedra. Which of the following species of Trichosporon causes scalp hair white piedra ? a) T. ovoides b) T. inkin c) T. asahii d) None of the above 4. All of the following are the characteristics of cutaneous mycoses, EXCEPT ? a) The infection of hair, skin, and nails b) The common cause of ringworm in humans only c) Candida spp is associated with the infection d) The keratinize...